Rchr
J-GLOBAL ID:201901018702120600   Update date: Jan. 30, 2024

Ryohei Miyazaki

ミヤザキ リョウヘイ | Ryohei Miyazaki
Research theme for competitive and other funds  (1):
  • 2012 - 2015 Depelopment of Porphysomes photoenhancer enabled bronchoscopic photothermal ablation
Papers (4):
  • Masahiko Higashiyama, Ryohei Miyazaki, Hiroshi Yamamoto, Takashi Anayama, Shinya Kikuchi, Kentaro Hirohashi, Jiro Okami, Tomohiro Maniwa, Toru Kimura, Kazumasa Orihashi, et al. Preoperative AminoIndex Cancer Screening (AICS) abnormalities predict postoperative recurrence in patients undergoing curative resection for non-small cell lung cancer. BMC cancer. 2020. 20. 1. 1100-1100
  • Takashi Anayama, Takayuki Sato, Kentaro Hirohashi, Ryohei Miyazaki, Marino Yamamoto, Hironobu Okada, Kazumasa Orihashi, Keiji Inoue, Michiya Kobayashi, Masashi Yoshida, et al. Near-infrared fluorescent solid material for visualizing indwelling devices implanted for medical use. Surgical endoscopy. 2020. 34. 9. 4206-4213
  • Takashi Anayama, Masahiko Higashiyama, Hiroshi Yamamoto, Shinya Kikuchi, Atsuko Ikeda, Jiro Okami, Toshiteru Tokunaga, Kentaro Hirohashi, Ryohei Miyazaki, Kazumasa Orihashi. Post-operative AICS status in completely resected lung cancer patients with pre-operative AICS abnormalities: predictive significance of disease recurrence. Scientific reports. 2018. 8. 1. 12378-12378
  • Ryohei Miyazaki, Takashi Anayama, Kentaro Hirohashi, Hironobu Okada, Motohiko Kume, Kazumasa Orihashi. In Vitro Drug Sensitivity Tests to Predict Molecular Target Drug Responses in Surgically Resected Lung Cancer (vol 11, e0152665, 2016). PLOS ONE. 2016. 11. 11. e0152665
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page